Niva Bupa Health Insurance Company Limited has informed the Exchange regarding a press release dated November 03, 2025, titled "Unaudited Financial Results for the quarter and half year ended September, 2025.".
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.0 pts more than Nifty Smallcap 250 and 3.9 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Niva Bupa reported a strong Q2 FY26, with IFRS Profit After Tax more than doubling to ₹62 crore from ₹24 crore in Q2 FY25, a growth of over 150%. Retail Health Gross Written Premium (GWP) rose 24.5% year-on-year, while overall GWP stood at ₹2,108 crore (excluding the 1/n method). H1 FY26 total GWP reached ₹3,983 crore. The Combined Insurance Service Ratio improved by 141 basis points to 103.1%, and the Claims Settlement Ratio rose to 95.2%. The Solvency Ratio strengthened to 2.85x, well above the regulatory minimum. The company now covers 23.14 million lives and reported an NPS of 57.
Sharp PAT growth and improving underwriting metrics signal strong operational momentum and financial health, likely to be viewed positively by the market. The retail health GWP growth of 24.5% and post-GST exemption demand tailwinds reinforce the company's growth outlook, though a combined ratio above 100% still indicates underwriting losses being offset by investment income.